Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Announces FDA Acceptance
.
Show all posts
Showing posts with label
Announces FDA Acceptance
.
Show all posts
Saturday, April 11, 2026
Arvinas Announces FDA Acceptance of the New Drug Application for Vepdegestrant for the Treatment of ESR1m, ER+/HER2- Advanced Breast Cancer
›
Arvinas, Inc. (Nasdaq: ARVN), today with its partner Pfizer Inc. (NYSE: PFE), announced that the U.S. Food and Drug Administration (FDA) has...
›
Home
View web version
